Sagamihara, Japan

Mari Nakatani



Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mari Nakatani: Innovator in Antimicrobial Compounds

Introduction

Mari Nakatani is a prominent inventor based in Sagamihara, Japan. She has made significant contributions to the field of chemistry, particularly in the development of compounds with antimicrobial properties. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to advancing scientific knowledge.

Latest Patents

Nakatani holds a patent for "Imidazothiazole derivatives and process for producing the same." This invention relates to compounds of formula (I), where X represents a halogen atom, and R represents the group —COR. In this context, R can be an alkoxy group or a hydrogen atom, an alkali metal, or an alkaline earth metal. The compounds developed through this process serve as synthetic intermediates, enabling the efficient and safe production of carbapenem derivatives that exhibit potent antimicrobial activity at a low cost.

Career Highlights

Throughout her career, Mari Nakatani has worked with notable companies, including Meiji Seika Kaisha, Ltd. and Sagami Chemical Research Center. Her experience in these organizations has allowed her to refine her skills and contribute to various research projects that focus on innovative chemical solutions.

Collaborations

Nakatani has collaborated with esteemed colleagues such as Eiki Shitara and Kunio Atsumi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.

Conclusion

Mari Nakatani's contributions to the field of chemistry, particularly through her patent on imidazothiazole derivatives, highlight her role as an innovator in antimicrobial compounds. Her work not only advances scientific understanding but also has practical applications in the development of effective antimicrobial agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…